By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DiscoverX Corporation 

42501 Albrae Street

Fremont  California  94538  U.S.A.
Phone: 510-979-1415 Fax: 510-979-1650


DiscoverX Corporation, headquartered in Fremont, CA, USA, is a leader in the design, manufacture and sale of biochemical and cell-based assays for the drug discovery & life science markets. This industry-leading portfolio of products and services, under the KINOMEscan®, PathHunter® and BioMAP® brands, are used to aid life science research and enable rapid development of safe and effective biologic and small molecule drugs, by improving research productivity, effectiveness of screening, lead optimization & bioanalytical campaigns, as well as providing predictive tools that deliver physiologically relevant insights on drug molecules from early discovery through pre-clinical development. DiscoverX embodies an innovative approach to creating life science tools that have been widely adopted across the globe in pharmaceutical, biotechnology and academic laboratories.

Key Statistics

Ownership: Private

Web Site: DiscoverX


Company News
DiscoverX And The SGC Announce Major Milestone In Development Of Kinase Chemogenomic Set 8/3/2017 11:03:40 AM
DiscoverX Release: Rapidly Screen Molecules For Novel Immuno-Oncology Therapeutics With Checkpoint Receptor Screening And Profiling Services 2/27/2017 7:58:13 AM
DiscoverX Launches Services For Early Identification of Potential Drug Side Effects 9/19/2016 10:59:49 AM
DiscoverX Launches Cell-Based Assays For Confirmation Of Compound-Target Engagement In Drug Discovery 9/19/2016 9:37:37 AM
DiscoverX Launches KILR Assay Platform For Use In Cancer Immunotherapy Drug Development 3/29/2016 8:15:28 AM
Easily Measure Cancer Cell Death In A Co-Culture With KILR Assays From DiscoverX 2/1/2016 7:32:19 AM
Rapidly Develop Drugs Targeting Interleukins With New PathHunter Cell-Based Assays From DiscoverX 1/5/2016 7:39:52 AM
DiscoverX Announces Extension Of Agreement With Blueprint Medicines (BPMC) 12/8/2015 9:16:38 AM
DiscoverX Enables Predictive In Vitro Drug Combination Studies With Launch Of Biomap® Combo ELECT 5/21/2014 10:05:45 AM
DiscoverX Platforms For Phenotypic And Target Based Screening Provide Unique Tools For Cancer Therapeutic Discovery 4/7/2014 10:51:46 AM